Search results
Showing 91 to 105 of 1338 results for 0
Denosumab for the prevention of osteoporotic fractures in postmenopausal women (TA204)
Evidence-based recommendations on denosumab (Prolia) for preventing osteoporotic fragility fractures in postmenopausal women.
Evidence-based recommendations on selinexor (Nexpovio) with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments in adults.
LARS for reconstructing damaged intra-articular cruciate knee ligaments (MIB30)
NICE has developed a medtech innovation briefing (MIB) on LARS for reconstructing damaged intra-articular cruciate knee ligaments
Pemetrexed for the treatment of malignant pleural mesothelioma (TA135)
Evidence-based recommendations on pemetrexed for treating malignant pleural mesothelioma in adults.
The section of the NICE impact lung cancer report looking at the diagnosis and staging process of lung cancer care.
In development [GID-TA11445] Expected publication date: TBC
Insertion of neo-chordae into the beating heart for mitral regurgitation
In development [GID-IPG10216] Expected publication date: TBC
Evidence-based recommendations on atogepant (Aquipta) for preventing migraine in adults.
Evidence-based recommendations on durvalumab (Imfinzi) with gemcitabine and cisplatin for treating locally advanced, unresectable, or metastatic biliary tract cancer in adults.
The PressureWire fractional flow reserve measurement system for coronary artery disease (MIB2)
NICE has developed a Medtech Innovation Briefing (MIB) on the PressureWire fractional flow reserve measurement system
This quality standard covers care for adults (aged 18 and over) with suspected or confirmed pneumonia. It includes diagnosing and managing community-acquired pneumonia. It describes high-quality care in priority areas for improvement.
View quality statements for QS110Show all sections
Sections for QS110
- Quality statements
- Quality statement 1: Mortality risk assessment in primary care using CRB65 score
- Quality statement 2: Antibiotic therapy for diagnosed low-severity community-acquired pneumonia
- Quality statement 3: Chest X-ray and diagnosis within 4 hours of hospital presentation
- Quality statement 4: Mortality risk assessment in hospital using CURB65 score
- Quality statement 5: Antibiotic therapy within 4 hours in hospital
- Update information
- About this quality standard
Photorefractive (laser) surgery for the correction of refractive errors (IPG164)
Evidence-based recommendations on photorefractive (laser) surgery for the correction of refractive errors. This involves using a special laser to permanently change the shape of the cornea.
View recommendations for IPG164Show all sections
Sections for IPG164
Evidence-based recommendations on minimally invasive oesophagectomy. This involves making small cuts or holes in the chest wall and inserting a camera and other instruments into the chest cavity to carry out the operation.
View recommendations for IPG407Show all sections
Sections for IPG407
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis
Evidence-based recommendations on thoracoscopically assisted mitral valve surgery. This involves repairing a defective valve through one or more small incisions between the ribs rather than one large incision through the breastbone (sternum).
View recommendations for IPG245Show all sections
Sections for IPG245